{"id":21015,"date":"2019-10-10T12:56:40","date_gmt":"2019-10-10T10:56:40","guid":{"rendered":"http:\/\/blog.netspark.de\/?p=21015"},"modified":"2019-10-09T13:21:43","modified_gmt":"2019-10-09T11:21:43","slug":"21015","status":"publish","type":"post","link":"https:\/\/blog.netspark.de\/?p=21015","title":{"rendered":"Johnson&#038;Johnson sued for $8 billion"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-Post-Thumb wp-image-21016\" src=\"https:\/\/blog.netspark.de\/wp-content\/uploads\/2019\/10\/JandJlogo-64x64.png\" alt=\"\" width=\"64\" height=\"64\" srcset=\"https:\/\/blog.netspark.de\/wp-content\/uploads\/2019\/10\/JandJlogo-64x64.png 64w, https:\/\/blog.netspark.de\/wp-content\/uploads\/2019\/10\/JandJlogo-150x150.png 150w, https:\/\/blog.netspark.de\/wp-content\/uploads\/2019\/10\/JandJlogo.png 256w\" sizes=\"auto, (max-width: 64px) 100vw, 64px\" \/>We all know that lawsuits with ridiculously high sums are<br \/>\ncommon in the USA, especially when it comes to lawsuits<br \/>\nagainst non-american companies. But in this case a lawsuit<br \/>\nfiled against Johnson&amp;Johnson is getting our attention.<\/p>\n<p><!--more-->The plaintiff is Nicholas Murray who set the lawsuit against the company in 2013 stating that he grew woman-like breasts while taking the anti-psycotic drug &#8220;Risperdal&#8221; when being a boy. It seems as if Johnson&amp;Johnson is faced with more than 10.000 similar lawsuits about similar drugs that had unwanted side effects to those who took them.<\/p>\n<p>A Philadelphia jury on Tuesday hit Johnson&amp;Johnson with an <strong>$8 billion(!)<\/strong> verdict over its marketing of the anti-psychotic drug Risperdal, siding with Nicholas Murray from Maryland who argued that the healthcare giant downplayed risks that the drug could lead to breast growth in men.<\/p>\n<p>Not only is this the highest lawsuit sum ever spoken out against a company in the USA but also the highest sum in favor for one person. Since this sum is ridiculous and totally unrational, Johnson&amp;Johnson already stated that they will definitely fight the verdict with all possible remedy.<\/p>\n<p>The lawsuit further declares: The plaintiff said that he grew breasts \u2014 a side-effect known as gynecomastia \u2014 when he started using Risperdal in 2003 to treat symptoms of autism. At that time the plaintiff was aged 9 and thus a boy. Probably the drug had a stronger impact on young males than on adult males. The lawsuit accused Janssen of failing to warn doctors about Risperdal\u2019s risks while improperly marketing it as a treatment for certain mental health disorders in children.<\/p>\n<p>This is the statement of the plaintiff&#8217;s lawyers (Mr. Kline and Jason Itkin):<\/p>\n<div class=\"post_citation\">\u201cThis jury resoundingly told Johnson &amp; Johnson that its actions were deliberate and malicious. The conduct that the jury saw in the courtroom was clear and convincing that J&amp;J disregarded the safety of the most vulnerable of children. This is an important moment, not only for this litigation, but for J&amp;J, which is a company that has lost its way.\u201d<\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We all know that lawsuits with ridiculously high sums are common in the USA, especially when it comes to lawsuits against non-american companies. But in this case a lawsuit filed against Johnson&amp;Johnson is getting our attention.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[342,434,3,3240,2949,19],"tags":[4057,4056,4054,600,4055,4058,36],"class_list":["post-21015","post","type-post","status-publish","format-standard","hentry","category-economyfinance","category-nature-2","category-news","category-science","category-technology","category-thoughts-2","tag-disorder","tag-drug","tag-johnson-and-johnson","tag-lawsuit","tag-pharmazeutical","tag-philadelphia","tag-usa"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/blog.netspark.de\/index.php?rest_route=\/wp\/v2\/posts\/21015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.netspark.de\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.netspark.de\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.netspark.de\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.netspark.de\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21015"}],"version-history":[{"count":0,"href":"https:\/\/blog.netspark.de\/index.php?rest_route=\/wp\/v2\/posts\/21015\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.netspark.de\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.netspark.de\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.netspark.de\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}